Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Detection of exocytic proteins in endothelial cells treated with high glucose and protease inhibitor

ABSTRACT: Endothelial cells were treated with high glucose and high glucose plus ADAM10 protease inhibitor, and the conditioned medium was collected for proteomic analysis

ORGANISM(S): Homo Sapiens

SUBMITTER: Mengnan Li

PROVIDER: PXD066579 | iProX | Fri Jul 25 00:00:00 BST 2025

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

SWATH-Proteomics of Mathurameha in High Glucose-Induced Endothelial Dysfunction

Project description:This study aimed to elucidate the mechanisms underlying the anti-diabetic effects of Mathurameha against high glucose-induced endothelial dysfunction by SWATH-MS. The EA.hy926 cells were treated with normal glucose, high glucose, or high glucose plus Mathurameha for 24 h. Proteins were extracted and resolved on 12% SDS-PAGE. Coomassie blue-stained gel were excised in the whole lane and subjected to in-gel tryptic digestion and SWATH-MS.

2024-05-31 | PXD052751 | JPOST Repository

Genome-wide analysis of High glucose-induced gene expression by Ninjurin1 siRNA

2014-05-20 | GSE57525 | GEO

Genome-wide analysis of High glucose-induced gene expression by DKK2 protein

2018-05-04 | GSE95178 | GEO

Genome-wide analysis of High glucose-induced gene expression by Ninjurin1 siRNA

Project description:Transcriptional profiling of Mouse cavernous primary endothelial cells (MCECs) in comparing normal glucose condition with high glucose condition or Ninjurin1 siRNA transfection condition. Objective was to determine the effect of ninjurin1 on high glucose conditioned cells on global gene expression. Total RNA obtained from MCECs, which were treated with High glucose (HG) condition or (HG+ninjurin1 siRNA). Biological replicates: 1 control replicates, 1 HG replicates, 1 (HG+ninjurin1 siRNA) replicates.

2014-05-20 | E-GEOD-57525 | biostudies-arrayexpress

Long term high glucose exposure in retinal endothelial cells

Project description:RNA-seq was performed on 4-week high glucose (25mM D-glucose) treated human retinal microvascular endothelial cells (HRMECs) and control (5mM D-glucose) passage-matched cells.

2022-09-20 | GSE199548 | GEO

Investigate the effect of high-glucose treatment in mouse endothelial cell

Project description:Freshly isolated murine skin endothelial cells were treated with high glucose and control with normal glucose.

2025-01-23 | GSE280770 | GEO

Long term high glucose exposure in retinal endothelial cells

Project description:Long term high glucose exposure in retinal endothelial cells

| PRJNA820706 | ENA

High glucose levels increase influenza-associated damage to the pulmonary epithelial-endothelial barrier

Project description:Here, the effects of high glucose levels on influenza severity were investigated using an in vitro model of the pulmonary epithelial-endothelial barrier. We show that compared to low glucose levels, high glucose conditions prior to influenza A virus infection increased virus-induced barrier damage. Increased barrier damage was not associated with increased cell death nor increased virus replication, but rather an increased pro-inflammatory response in endothelial cells and the subsequent damage of the epithelial junctional complex.

2020-02-14 | GSE145232 | GEO

Investigate the effect of high-glucose treatment in mouse endothelial cell

Project description:Investigate the effect of high-glucose treatment in mouse endothelial cell

| PRJNA1180515 | ENA

Studies on mature endothelial cells; exploring mechanisms for improvement of cardiovascular diseases

Project description:Transcriptomic analysis of primary human umbilical vein endothelial cells (HUVEC). HUVEC were treated in vitro with CoCl2 to induce hypoxia, high glucose and high glucose plus hypoxia in different intervals (1, 3, 12 hours). Subsequently, the effect of metformin (anti-diabetic drug) on all conditions was studied to take advantage of transcriptomics to prospectively explore the mechanism of this drug to reduce the risk of cardiovascular diseases in type II diabetic patients.

2014-12-03 | GSE46263 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data